期刊文献+

文拉法辛对美沙酮镇痛作用的影响 被引量:4

An Experimental Study on Venlafaxine Multiplying Analgesic Effect of Methadone Hydrocloride
下载PDF
导出
摘要 目的 :对文拉法辛增强美沙酮的镇痛作用进行动物实验观察。方法 :将小鼠随机分成 5组 (n =10 ) ,生理盐水组 (A组 ) ,盐酸美沙酮组 (B组 ) ,盐酸美沙酮加低剂量文拉法辛组 (C1组 ) ,盐酸美沙酮加中剂量文拉法辛组 (C2组 ) ,盐酸美沙酮加高剂量文拉法辛组 (C3组 ) ,通过扭体法和热板法观察文拉法辛对美沙酮的镇痛作用的影响。结果 :C2组和C3组与B组比较均可明显减少小鼠的扭体次数 ,疼痛潜伏期延长 ,痛阈百分率提高。结论 :对化学刺激法致痛和热板法致痛的小鼠文拉法辛能够增强美沙酮的镇痛作用 ,二者具有协同作用。 Objective:To make an animal experimental observation of venlafaxine multiplying analgesic effect of methadone hydrocloride.Methods:Mice models were randomly divided into five groups ((n=)10),the first group(Group A) was given NS,the second group (Group B) methadone,the third group(Group C1) low dose of venlafaxine and methadone,the fourth group(Group C2) medium dose of venlafaxine and methadone,the fifth group (Group C3) high dose of venlafaxine and methadone.Twist reaction and hot board reaction were used to observe venlafaxine multiplying analgesic effect of methadone hydrocloride.Results:High or medium dose of venlafaxine added to methadone(Group C2 and Group C3) obviously reduced the frequency of twist reaction in the experimental mice,and latent period of pain was prolonged and pain threshold improved.Conclusion:Venlafaxine can multiply the analgesic effect of methadone,they have synergism.
作者 何巧燕
机构地区 山西职工医学院
出处 《山西职工医学院学报》 CAS 2005年第1期1-2,共2页 Journal of Shanxi Medical College for Continuing Education
关键词 扭体反应 潜伏期 痛阈百分率 twist reation latent period pain threshold
  • 相关文献

参考文献4

  • 1徐淑云.药理实验方法学[M].北京:人民卫生出版社,1994.1106-7.
  • 2金有豫.药理学[M].北京:人民卫生出版社,2001.139.
  • 3郑斯聚.美沙酮的药理和临床应用[J].中华麻醉学杂志,2002,22(10):639-640. 被引量:9
  • 4DipiroJT.Pharmacotherapy[M].北京:科学出版社,2000.258.

二级参考文献15

  • 1Ripamonti C, Dickerson ED. Strategies for the treatment of cancery pain in the new millennium. Drugs, 2001,61: 955-977.
  • 2Dundee JW, Clarke RSJ, McCaughey W, ed. Clinical anaesthetic pharmacology. Edinbrugh: Churchill Livingstone, 1991.214.
  • 3Mancini I, Lossignol DA, Body JJ. Opioid switching to oral methadone in cancer pain. Curr Opin Oncol, 2000, 12:308-313.
  • 4Boulton DW, Arnaud P, De Vane CL. Pharmacokinetics and pharmacodynamics of methadone enantiomers. Clin Pharmacol Ther,2001, 70:48-57.
  • 5Ripamonti C, Zecca E, Bruera E. An update on the clinical use of methadone for cancer pain. Pain, 1997, 70:109-115.
  • 6Lawlor PG, Turner K, Hanson J, et al. Dose ratio between morphine to oral methadone in patients with cancer pain:a retrospective study.Cancer, 1998, 82:1167-1173.
  • 7Reynolds JEF, ed. Martindale. The extra pharmacopoeia. London:Royal Pharmaceut Soc, 1996.60-62.
  • 8Abramson FP. Methadone plasma protein binding: alterations in cancer and displacement from at-acid glycoprotein. Clin Pharmacol Ther, 1982, 32: 652-658.
  • 9Inturrisi CE, Porteney RK, Max MB, et al. Pharmacokineticpharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther, 1990, 47: 565-577.
  • 10Inturrisi CE, Colburn WA, Kaiko RF, et al. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther, 1987, 41: 392-401.

共引文献163

同被引文献18

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部